Human CXCL10/IP-10/CRG-2 Antibody, R&D Systems™

Mouse Monoclonal Antibody

Catalog Number	Mfr. No.	Quantity
MAB266SP	R&D Systems MAB266SP	25 μg
MAB266100	R&D Systems MAB266100	100 μg
MAB266500	R&D Systems MAB266500	500 μg

Description

CXCL10/IP-10/CRG-2 Monoclonal specifically detects CXCL10/IP-10/CRG-2 in Human samples. It is validated for Neutralization, Intracellular Staining by Flow Cytometry, CyTOF-ready, ELISA Capture (Matched Antibody Pair).

Specifications

• Antigen: CXCL10/IP-10/CRG-2
• Dilution: Western Blot 1 ug/mL, Neutralization 0.5-2.0 ug/mL, Intracellular Staining by Flow Cytometry 2.5 ug/10^6 cells, CyTOF-ready, ELISA Capture (Matched Antibody Pair) 2-8 ug/mL
• Classification: Monoclonal
• Host Species: Mouse
• Target Species: Human
• Gene Accession No.: P02778.2
• Gene ID (Entrez): 3627
• Immunogen: E. coli-derived recombinant human CXCL10/IP-10/CRG-2 Val22-Pro98 Accession # P02778.2
• Primary or Secondary: Primary
• Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
• Test Specificity: Detects human CXCL10/IP-10/CRG-2 in ELISAs and Western blots. In Western blots, does not cross-react with recombinant human CXCL1, 2, 3, 5, 8, 9, 12/SDF-1 beta , recombinant mouse CXCL1, or 2.

• Clone: 33036
• Applications: Western Blot, Neutralization, Flow Cytometry, CyTOF, ELISA
• Conjugate: Unconjugated
• Regulatory Status: RUO
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
• Gene Alias: C7, chemokine (C-X-C motif) ligand 10, crg-2, CRG2, gIP-10, IFI10, INP10, IP-10, mob-1, SCYB10
• Gene Symbols: CXCL10
• Isotype: IgG1
• Purification Method: Protein A or G purified from ascites
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.